The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ASP-5878 ID: ALA4594428
Cas Number: 1453208-66-6
PubChem CID: 71736582
Product Number: A413509, Order Now?
Max Phase: Phase
Molecular Formula: C18H19F2N5O4
Molecular Weight: 407.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: Asp 5878 | Asp-5878 | Asp5878 | ASP-5878 | ASP5878 | ASP5878|ASP-5878|1453208-66-6|Asp 5878|1H-Pyrazole-1-ethanol, 4-((5-((2,6-difluoro-3,5-dimethoxyphenyl)methoxy)-2-pyrimidinyl)amino)-|ASP 5878 [WHO-DD]|C0Z095LL72|1453208-66-6 (free base)|2-(4-((5-((2,6-difluoro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-1H-pyrazol-1-yl)ethanol|2-[4-[[5-[(2,6-difluoro-3,5-dimethoxyphenyl)methoxy]pyrimidin-2-yl]amino]pyrazol-1-yl]ethanol|2-[4-({5-[(2,6-difluoro-3,5-dimethoxybenzyl)oxy]pyrimidin-2-yl}amino)-1 Show More⌵
Canonical SMILES: COc1cc(OC)c(F)c(COc2cnc(Nc3cnn(CCO)c3)nc2)c1F
Standard InChI: InChI=1S/C18H19F2N5O4/c1-27-14-5-15(28-2)17(20)13(16(14)19)10-29-12-7-21-18(22-8-12)24-11-6-23-25(9-11)3-4-26/h5-9,26H,3-4,10H2,1-2H3,(H,21,22,24)
Standard InChI Key: VDZZYOJYLLNBTD-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
4.5029 -2.6649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2175 -2.2525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9294 -2.6645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9294 -3.4897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2193 -3.9015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5029 -3.4934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6439 -3.9022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3584 -3.4897 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0729 -3.9022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7875 -3.4899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4995 -3.9018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4995 -4.7270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7893 -5.1389 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0729 -4.7307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2139 -5.1396 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.9284 -4.7270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6835 -5.0592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2296 -4.4505 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8186 -3.7384 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0184 -3.9071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2311 -3.0240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0561 -3.0240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4686 -2.3095 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7884 -3.9059 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2175 -1.4275 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2193 -4.7265 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.6439 -2.2520 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.5030 -1.0151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7884 -4.7309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
4 7 1 0
7 8 1 0
8 9 1 0
10 9 2 0
11 10 1 0
12 11 2 0
13 12 1 0
14 13 2 0
9 14 1 0
12 15 1 0
15 16 1 0
17 16 1 0
17 18 2 0
18 19 1 0
19 20 1 0
20 16 2 0
19 21 1 0
21 22 1 0
22 23 1 0
6 24 1 0
2 25 1 0
5 26 1 0
3 27 1 0
25 28 1 0
24 29 1 0
M END
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: YesAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 407.38Molecular Weight (Monoisotopic): 407.1405AlogP: 2.28#Rotatable Bonds: 9Polar Surface Area: 103.55Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.87CX Basic pKa: 1.63CX LogP: 1.44CX LogD: 1.44Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.56Np Likeness Score: -1.29
References 1. Unpublished dataset, 2. Kuriwaki I, Kameda M, Iikubo K, Hisamichi H, Kawamoto Y, Kikuchi S, Moritomo H, Terasaka T, Iwai Y, Noda A, Tomiyama H, Kikuchi A, Hirano M.. (2022) Discovery of ASP5878: Synthesis and structure-activity relationships of pyrimidine derivatives as pan-FGFRs inhibitors with improved metabolic stability and suppressed hERG channel inhibitory activity., 59 [PMID:35219181 ] [10.1016/j.bmc.2022.116657 ] 3. Zhong Z, Shi L, Fu T, Huang J, Pan Z.. (2022) Discovery of Novel 7-Azaindole Derivatives as Selective Covalent Fibroblast Growth Factor Receptor 4 Inhibitors for the Treatment of Hepatocellular Carcinoma., 65 (10.0): [PMID:35549181 ] [10.1021/acs.jmedchem.2c00255 ] 4. Zhang X, Wang Y, Ji J, Si D, Bao X, Yu Z, Zhu Y, Zhao L, Li W, Liu J.. (2022) Discovery of 1,6-Naphthyridin-2(1H )-one Derivatives as Novel, Potent, and Selective FGFR4 Inhibitors for the Treatment of Hepatocellular Carcinoma., 65 (11.0): [PMID:35635004 ] [10.1021/acs.jmedchem.1c01977 ]